Search

everythinglearnresearchcommunity

for

Search:↓

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Cynatine HNS improves hair and nail quality in 90 days.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Children are at risk of health issues from exposure to platinum group elements from car exhausts.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Finasteride may cause kidney damage.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

New nano composite helps reduce scars and regrow hair during burn wound healing.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.